E.e.s
Product Images NDC 80005-152

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for E.e.s (NDC 80005-152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carnegie Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ees 01)

Chemical Structure (Ees 01)
Chemical structure diagram of the active ingredient in the product E.E.S. The structure includes multiple ring systems and various functional groups, as typically seen in complex organic molecules.*
FDA Label Image

Principal Display Panel (400 mg Tablet Bottle Label)

Principal Display Panel (400 mg Tablet Bottle Label)
Label for E.E.S 400 Film-coated Tablets by Carnegie Pharmaceuticals LLC. Contains erythromycin ethylsuccinate equivalent to 400 mg erythromycin activity. Package includes 30 tablets with an NDC of 80005-161-08. The label provides storage instructions, dosage guidance, and warnings. Barcodes and serialization space are also visible.*
FDA Label Image

Principal Display Panel (100 mL Bottle Label)

Principal Display Panel (100 mL Bottle Label)
Label for E.E.S. Granules, erythromycin ethylsuccinate oral suspension reconstituted to 200 mg erythromycin activity per 5 mL. The 100 mL suspension is for oral use only, labeled by Carnegie Pharmaceuticals LLC. Directions for mixing and storage instructions are included, with detailed dosing notes for children and adults.*
FDA Label Image

Principal Display Panel (200 mL Bottle Label)

Principal Display Panel (200 mL Bottle Label)
Label for E.E.S. Granules oral suspension by Carnegie Pharmaceuticals LLC, showing erythromycin ethylsuccinate for oral suspension USP with erythromycin activity of 200 mg per 5 mL when reconstituted. The label includes NDC 80005-153-34, mixing directions, dosage information, storage instructions, and manufacturer details.*
FDA Label Image

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.